Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis

por Wang, Xiaoyan, Wang, Jian-Ping, Maughan, Maureen F, Lachman, Lawrence B
Publicado 2005

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

por Eralp, Yesim, Wang, Xiaoyan, Wang, Jian-Ping, Maughan, Maureen F, Polo, John M, Lachman, Lawrence B
Publicado 2004

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity

por Avogadri, Francesca, Merghoub, Taha, Maughan, Maureen F., Hirschhorn-Cymerman, Daniel, Morris, John, Ritter, Erika, Olmsted, Robert, Houghton, Alan N., Wolchok, Jedd D.
Publicado 2010

Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials

por Whitley, Jill, Zwolinski, Christopher, Denis, Christian, Maughan, Maureen, Hayles, Leonie, Clarke, David, Snare, Meghan, Liao, Hong, Chiou, Sean, Marmura, Tina, Zoeller, Holly, Hudson, Ben, Peart, John, Johnson, Monica, Karlsson, Amelia, Wang, Yunfei, Nagle, Cynthia, Harris, Cherell, Tonkin, Daniel, Fraser, Stephanie, Capiz, Lieza, Zeno, Christina L., Meli, Yvonne, Martik, Diana, Ozaki, Daniel A., Caparoni, Amy, Dickens, Jason E., Weissman, Drew, Saunders, Kevin O., Haynes, Barton F., Sempowski, Gregory D., Denny, Thomas N., Johnson, Matthew R.
Publicado 2022